Revisiting physical distancing threshold in indoor environment using infection-risk-based modeling. 2021

Fan Liu, and Zhiwen Luo, and Yuguo Li, and Xiaohong Zheng, and Chongyang Zhang, and Hua Qian
School of Energy and Environment, Southeast University, Nanjing, China; School of the Built Environment, University of Reading, Reading, United Kingdom.

Physical distancing has been an important policy to mitigate the spread of the novel coronavirus disease 2019 (COVID-19) in public settings. However, the current 1-2 m physical distancing rule is based on the physics of droplet transport and could not directly translate into infection risk. We therefore revisit the 2-m physical distancing rule by developing an infection-risk-based model for human speaking. The key modeling framework components include viral load, droplets dispersion and evaporation, deposition efficiency, viral dose-response rate and infection risk. The results suggest that the one-size-fits-all 2-m physical distancing rule derived from the pure droplet-physics-based model is not applicable under some realistic indoor settings, and may rather increase transmission probability of diseases. Especially, in thermally stratified environments, the infection risk could exhibit multiple peaks for a long distance beyond 2 m. With Sobol's sensitivity analysis, most variance of the risk is found to be significantly attributable to the variability in temperature gradient, exposure time and breathing height difference. Our study suggests there is no such magic 2 m physical distancing rule for all environments, but it needs to be used alongside other strategies, such as using face cover, reducing exposure time, and controlling the thermal stratification of indoor environment.

UI MeSH Term Description Entries
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000085762 Physical Distancing Maintaining recommended amount of spatial separation between self and others. Physical Distance,Social Distancing,Distance, Physical,Distancing, Physical,Distancing, Social
D000086382 COVID-19 A viral disorder generally characterized by high FEVER; COUGH; DYSPNEA; CHILLS; PERSISTENT TREMOR; MUSCLE PAIN; HEADACHE; SORE THROAT; a new loss of taste and/or smell (see AGEUSIA and ANOSMIA) and other symptoms of a VIRAL PNEUMONIA. In severe cases, a myriad of coagulopathy associated symptoms often correlating with COVID-19 severity is seen (e.g., BLOOD COAGULATION; THROMBOSIS; ACUTE RESPIRATORY DISTRESS SYNDROME; SEIZURES; HEART ATTACK; STROKE; multiple CEREBRAL INFARCTIONS; KIDNEY FAILURE; catastrophic ANTIPHOSPHOLIPID ANTIBODY SYNDROME and/or DISSEMINATED INTRAVASCULAR COAGULATION). In younger patients, rare inflammatory syndromes are sometimes associated with COVID-19 (e.g., atypical KAWASAKI SYNDROME; TOXIC SHOCK SYNDROME; pediatric multisystem inflammatory disease; and CYTOKINE STORM SYNDROME). A coronavirus, SARS-CoV-2, in the genus BETACORONAVIRUS is the causative agent. 2019 Novel Coronavirus Disease,2019 Novel Coronavirus Infection,2019-nCoV Disease,2019-nCoV Infection,COVID-19 Pandemic,COVID-19 Pandemics,COVID-19 Virus Disease,COVID-19 Virus Infection,Coronavirus Disease 2019,Coronavirus Disease-19,SARS Coronavirus 2 Infection,SARS-CoV-2 Infection,Severe Acute Respiratory Syndrome Coronavirus 2 Infection,COVID19,2019 nCoV Disease,2019 nCoV Infection,2019-nCoV Diseases,2019-nCoV Infections,COVID 19,COVID 19 Pandemic,COVID 19 Virus Disease,COVID 19 Virus Infection,COVID-19 Virus Diseases,COVID-19 Virus Infections,Coronavirus Disease 19,Disease 2019, Coronavirus,Disease, 2019-nCoV,Disease, COVID-19 Virus,Infection, 2019-nCoV,Infection, COVID-19 Virus,Infection, SARS-CoV-2,Pandemic, COVID-19,SARS CoV 2 Infection,SARS-CoV-2 Infections,Virus Disease, COVID-19,Virus Infection, COVID-19
D000086402 SARS-CoV-2 A species of BETACORONAVIRUS causing atypical respiratory disease (COVID-19) in humans. The organism was first identified in 2019 in Wuhan, China. The natural host is the Chinese intermediate horseshoe bat, RHINOLOPHUS affinis. 2019 Novel Coronavirus,COVID-19 Virus,COVID19 Virus,Coronavirus Disease 2019 Virus,SARS Coronavirus 2,SARS-CoV-2 Virus,Severe Acute Respiratory Syndrome Coronavirus 2,Wuhan Coronavirus,Wuhan Seafood Market Pneumonia Virus,2019-nCoV,2019 Novel Coronaviruses,COVID 19 Virus,COVID-19 Viruses,COVID19 Viruses,Coronavirus 2, SARS,Coronavirus, 2019 Novel,Coronavirus, Wuhan,Novel Coronavirus, 2019,SARS CoV 2 Virus,SARS-CoV-2 Viruses,Virus, COVID-19,Virus, COVID19,Virus, SARS-CoV-2,Viruses, COVID19

Related Publications

Fan Liu, and Zhiwen Luo, and Yuguo Li, and Xiaohong Zheng, and Chongyang Zhang, and Hua Qian
November 2021, Sustainable cities and society,
Fan Liu, and Zhiwen Luo, and Yuguo Li, and Xiaohong Zheng, and Chongyang Zhang, and Hua Qian
January 1995, Occupational medicine (Philadelphia, Pa.),
Fan Liu, and Zhiwen Luo, and Yuguo Li, and Xiaohong Zheng, and Chongyang Zhang, and Hua Qian
August 2021, Lancet (London, England),
Fan Liu, and Zhiwen Luo, and Yuguo Li, and Xiaohong Zheng, and Chongyang Zhang, and Hua Qian
August 2021, Lancet (London, England),
Fan Liu, and Zhiwen Luo, and Yuguo Li, and Xiaohong Zheng, and Chongyang Zhang, and Hua Qian
August 2021, Lancet (London, England),
Fan Liu, and Zhiwen Luo, and Yuguo Li, and Xiaohong Zheng, and Chongyang Zhang, and Hua Qian
August 2021, Lancet (London, England),
Fan Liu, and Zhiwen Luo, and Yuguo Li, and Xiaohong Zheng, and Chongyang Zhang, and Hua Qian
August 2021, Lancet (London, England),
Fan Liu, and Zhiwen Luo, and Yuguo Li, and Xiaohong Zheng, and Chongyang Zhang, and Hua Qian
August 2021, Lancet (London, England),
Fan Liu, and Zhiwen Luo, and Yuguo Li, and Xiaohong Zheng, and Chongyang Zhang, and Hua Qian
June 2012, Nihon rinsho. Japanese journal of clinical medicine,
Fan Liu, and Zhiwen Luo, and Yuguo Li, and Xiaohong Zheng, and Chongyang Zhang, and Hua Qian
August 2021, Lancet (London, England),
Copied contents to your clipboard!